MedTrace Logo

Impact of Pycnogenol® on Gingival Inflammation

NCT05786820 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2024-08-09

No results posted yet for this study

Summary

This randomized, double-blind, placebo-controlled 2-arm, parallel group clinical trial is designed to evaluate the impact of the regular consumption of a polyphenol-containing Maritime Pine (Pinus pinaster) bark extract (Pycnogenol®) on clinical signs of gingival inflammation in a cohort of periodontal aftercare patients

Conditions

  • Periodontitis

Interventions

DIETARY_SUPPLEMENT

Pycnogenol

daily consumption of a pycnogenol-containing capsule

DIETARY_SUPPLEMENT

Placebo

Daily consumption of a placebo capsule

Sponsors & Collaborators

  • University of Wuerzburg

    collaborator OTHER

  • Wuerzburg University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-17
Primary Completion
2024-07-20
Completion
2024-07-20

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05786820 on ClinicalTrials.gov